{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:28:55Z","timestamp":1748449735038},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1987,1,1]],"date-time":"1987-01-01T00:00:00Z","timestamp":536457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacologia"],"published-print":{"date-parts":[[1987]]},"DOI":"10.1007\/bf00690936","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T11:41:33Z","timestamp":1101728493000},"page":"104-108","source":"Crossref","is-referenced-by-count":35,"title":["The negative symptoms of schizophrenia and the monoamine oxidase inhibitors"],"prefix":"10.1007","volume":"91","author":[{"given":"Luigi","family":"Bucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.2042-7158.1972.tb08912.x","volume":"24","author":"EN Anden","year":"1972","unstructured":"Anden EN (1972) Dopamine turnover in the corpus striatum and limbic system after treatment with neuroleptics and antiacetylcholine drugs. J Pharm Pharmacol 24:905?906","journal-title":"J Pharm Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1749-6632.1959.tb49243.x","volume":"80","author":"Sd'A Bailey","year":"1959","unstructured":"Bailey Sd'A, Bucci L, Gosline E, Kline NS et al. (1959) Comparison of iproniazid with other monoamine oxidase inhibitors including W-1544, JB-516, RO-4-1018 and RO-5-700. Ann NY Acad Sci 80:652?667","journal-title":"Ann NY Acad Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.ne.03.030180.000323","volume":"3","author":"R Baldessarini","year":"1980","unstructured":"Baldessarini R, Tarsy D (1980) Dopamine and pathophysiology of dyskenesia induced by antipsychotic drugs. Ann Rev Neurosci 3:23?41","journal-title":"Ann Rev Neurosci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01246960","volume":"45","author":"W Birkmayer","year":"1978","unstructured":"Birkmayer W (1978) Long-term treatment with 1-deprenyl. J Neural Transm 45:239?244","journal-title":"J Neural Transm"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(64)92914-9","volume":"II","author":"B Blackwell","year":"1964","unstructured":"Blackwell B, Marley E (1964) Interaction between cheese and monoamine oxidase inhibitors. Lancet II:530?531","journal-title":"Lancet"},{"key":"CR6","first-page":"55","volume":"28","author":"L Bucci","year":"1967","unstructured":"Bucci L (1967) Monoamine oxidase inhibitors and schizophrenia. Dis Nerv Syst 28:55?59","journal-title":"Dis Nerv Syst"},{"key":"CR7","first-page":"127","volume":"29","author":"L Bucci","year":"1968","unstructured":"Bucci L (1968) The psychiatrist and the monoamine oxidase inhibitors. Dis Nerv Syst 29:127?130","journal-title":"Dis Nerv Syst"},{"key":"CR8","first-page":"843","volume":"30","author":"L Bucci","year":"1969","unstructured":"Bucci L (1969) The monoamine oxidase inhibitors: the usefulness and their safety. Dis Nerv Syst 30:843?847","journal-title":"Dis Nerv Syst"},{"key":"CR9","first-page":"324","volume":"32","author":"L Bucci","year":"1971","unstructured":"Bucci L (1971) The dyskinesia ? a new therapeutic approach. Dis Nerv Syst 32:324?327","journal-title":"Dis Nerv Syst"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/archpsyc.1975.01760260120010","volume":"32","author":"A Carenzi","year":"1953","unstructured":"Carenzi A, Gillin C, Guidotti A, Schwartz M, Wyatt RJ (1953) Dopamine sensitive adenylate cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients. Arch Gen Psychiatry 32:1056?1059","journal-title":"Arch Gen Psychiatry"},{"key":"CR11","unstructured":"Cole JO, Jone RT, Klermann GL (1961) Drugs therapy. In: Progress in neurology and psychiatry, vol. 16. pp 539?574"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.280.6207.66","volume":"12","author":"TJ Crow","year":"1980","unstructured":"Crow TJ (1980) Molecular pathology of schizophrenia: more than one process? Br Med J 12:66?68","journal-title":"Br Med J"},{"key":"CR13","first-page":"215","volume-title":"Monoamines et system nerveux centrale","author":"P Deniker","year":"1962","unstructured":"Deniker P (1962) Monoamines, m\u00e9dicaments psychtropiques et nosographie psychiatriques. In: de Ajuriagverra J (ed) Monoamines et system nerveux centrale. Masson, Paris, pp 215?232"},{"key":"CR14","first-page":"183","volume":"32","author":"O Hornykiewicz","year":"1973","unstructured":"Hornykiewicz O (1973) Parkinson's disease: From brain homogenates to treatment. Fed Proc 32:183?190","journal-title":"Fed Proc"},{"issue":"291","key":"CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0447.1981.tb02458.x","volume":"63","author":"DAW Johnson","year":"1981","unstructured":"Johnson DAW (1981a) Oral versus depot medication in schizophrenia. Acta Psychiatr Scand 63 (Suppl 291):56?64","journal-title":"Acta Psychiatr Scand"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1192\/bjp.139.2.89","volume":"139","author":"DAW Johnson","year":"1981","unstructured":"Johnson DAW (1981b) Studies of depressive symptoms in schizophrenia. The prevalence of depression and its possible causes. Br J Psychiatry 139:89?101","journal-title":"Br J Psychiatry"},{"key":"CR17","first-page":"233","volume-title":"Monoamine et system nerveux centrale","author":"P Kielholz","year":"1962","unstructured":"Kielholz P, Labhardt F (1962) D\u00e9ductions tir\u00e9es de nos connaissances sur les inhibiteurs de MAO par rapport \u00e0 la classification classiques des psychoses. In: de Ajuriagverra J (ed) Monoamine et system nerveux centrale. Masson Paris, pp 233?238"},{"key":"CR18","doi-asserted-by":"crossref","unstructured":"Knoll J (1983) Deprenyl (Selegiline): The history of its development and pharmacological action. Acta Neurol Scand (Supplement 95):57?94","DOI":"10.1111\/j.1600-0404.1983.tb01517.x"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.6310753","volume":"121","author":"M Memo","year":"1983","unstructured":"Memo M, Kleiman JE, Hanbauer I (1983) Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudate of schizophrenia. Science 121:1304?1307","journal-title":"Science"},{"key":"CR20","first-page":"204","volume":"II","author":"R MacLean","year":"1965","unstructured":"MacLean R, Nicholson WJ, Pare CMB et al. (1965) Effects of monoamine oxidase inhibitors on the concentration of 5-hydroxytryptamine in the human brain. Lancet II:204?208","journal-title":"Lancet"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799?912","journal-title":"Psychol Rep"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/B978-0-08-011195-7.50017-4","volume-title":"The scientific basis of drug therapy in psychiatry","author":"CMB Pare","year":"1965","unstructured":"Pare CMB (1965) Some clinical aspects of antidepressant drugs. In: Marks J, Pare CMB (eds) The scientific basis of drug therapy in psychiatry. Pergamon, NY, pp 103?113"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/bmj.1.5283.972","volume":"1","author":"CM Parkes","year":"1962","unstructured":"Parkes CM, Broan GW, Monk EM (1962) The general practitioner and the schizophrenic patients. Br Med J 1:972?973","journal-title":"Br Med J"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(82)90167-2","volume":"II","author":"SH Snyder","year":"1982","unstructured":"Snyder SH (1982) Neurotransmitters and C.N.S. diseases: Schizophrenia. Lancet II:970?973","journal-title":"Lancet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","volume":"35","author":"RL Spitzer","year":"1978","unstructured":"Spitzer RL, Edincott J, Robins E (1978) Research Diagnostic Criteria. Arch Gen Psychiatry 35:773?782","journal-title":"Arch Gen Psychiatry"},{"key":"CR26","first-page":"950","volume":"66","author":"P Tyrer","year":"1973","unstructured":"Tyrer P (1973) Are monoamine oxidase inhibitors antidepressant? Proc Soc Med 66:950?951","journal-title":"Proc Soc Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1192\/bjp.128.4.354","volume":"128","author":"P Tyrer","year":"1976","unstructured":"Tyrer P (1976) Toward rational therapy with monoamine oxidase inhibitors. Br J Psychiatry 128:354?360","journal-title":"Br J Psychiatry"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0306-4530(79)90039-8","volume":"4","author":"DP Kammen Van","year":"1979","unstructured":"Van Kammen DP (1979) The dopamine hypothesis of schizophrenia revisited. Psychoneuroendocrinology 4:37?46","journal-title":"Psychoneuroendocrinology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archpsyc.1978.01770330075006","volume":"35","author":"T Putten Van","year":"1978","unstructured":"Van Putten T, May PRA (1978) Akinetic depression. Arch Gen Psychiatry 35:1101?1107","journal-title":"Arch Gen Psychiatry"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cpt19623159","volume":"3","author":"G Werner","year":"1962","unstructured":"Werner G (1962) Clinical pharmacology of central stimulant and antidepressant drugs. Clin Pharmacol Ther 3:59?96","journal-title":"Clin Pharmacol Ther"},{"key":"CR31","first-page":"7","volume-title":"The benzamides: pharmacology, neurobiology and clinical aspects","author":"P Worms","year":"1983","unstructured":"Worms P (1983) Behavioral pharmacology of benzamides as compared to standard neuroleptics. In: Rotrosen J, Stanley M (eds) The benzamides: pharmacology, neurobiology and clinical aspects. Raven, New York, pp 7?16"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00690936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00690936\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00690936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:41:21Z","timestamp":1554835281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00690936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987]]}},"alternative-id":["BF00690936"],"URL":"https:\/\/doi.org\/10.1007\/bf00690936","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987]]}}}